Corline Biomedical AB | Income Statement
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
1,787.60
1,683.30
1,037.10
947.00
638.00
Cost of Goods Sold (COGS) incl. D&A
4,338.40
4,285.00
6,709.60
7,013.00
18,931.00
Gross Income
2,550.80
2,601.80
5,672.50
6,066.00
18,293.00
SG&A Expense
-
-
12.00
38.00
16.00
EBIT
2,417.10
2,501.80
5,676.30
5,220.00
7,809.00
Non Operating Income/Expense
-
-
169.00
28.00
1.00
Interest Expense
77.40
33.40
-
-
-
Pretax Income
2,487.80
2,512.20
5,845.30
5,248.00
7,810.00
Consolidated Net Income
2,487.80
2,512.20
5,845.30
5,248.00
7,810.00
Net Income
2,487.80
2,512.20
5,845.30
5,248.00
7,810.00
Net Income After Extraordinaries
2,487.80
2,512.20
5,845.30
5,248.00
7,810.00
Net Income Available to Common
2,487.80
2,512.20
5,845.30
5,248.00
7,810.00
EPS (Basic)
0.39
0.39
0.67
0.45
0.59
Basic Shares Outstanding
6,499.10
6,499.10
8,663.90
11,770.00
13,249.00
EPS (Diluted)
0.38
0.39
0.67
0.45
0.59
Diluted Shares Outstanding
6,499.10
6,499.10
8,663.90
11,770.00
13,249.00
EBITDA
2,390.00
2,468.00
5,648.20
5,219.00
7,808.00
Other Operating Expense
133.70
100.00
8.20
884.00
10,500.00
Non-Operating Interest Income
6.80
23.00
-
-
-
About Corline Biomedical AB
View Profile
